Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to -$4.7 million.

  • Jaguar Health's Free Cash Flow rose 2605.27% to -$4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$26.0 million, marking a year-over-year increase of 1028.99%. This contributed to the annual value of -$29.4 million for FY2024, which is 1155.77% up from last year.
  • Jaguar Health's Free Cash Flow amounted to -$4.7 million in Q3 2025, which was up 2605.27% from -$6.2 million recorded in Q2 2025.
  • Jaguar Health's Free Cash Flow's 5-year high stood at -$4.7 million during Q3 2025, with a 5-year trough of -$10.5 million in Q2 2022.
  • Over the past 5 years, Jaguar Health's median Free Cash Flow value was -$7.5 million (recorded in 2023), while the average stood at -$7.8 million.
  • Per our database at Business Quant, Jaguar Health's Free Cash Flow crashed by 22312.44% in 2021 and then skyrocketed by 2914.03% in 2024.
  • Quarter analysis of 5 years shows Jaguar Health's Free Cash Flow stood at -$8.9 million in 2021, then grew by 28.02% to -$6.4 million in 2022, then dropped by 16.0% to -$7.5 million in 2023, then fell by 5.03% to -$7.8 million in 2024, then surged by 40.08% to -$4.7 million in 2025.
  • Its Free Cash Flow was -$4.7 million in Q3 2025, compared to -$6.2 million in Q2 2025 and -$7.3 million in Q1 2025.